Variant report

Variant	esv1840021
Chromosome Location	chr2:171572702-171573980
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:277)
CpG islands
(count:490)
Chromatin interactive
region (count:4)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:277 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:171573367-171573706	HepG2	liver:	n/a	n/a
2	ATF3	chr2:171573402-171573659	HepG2	liver:	n/a	n/a
3	BACH1	chr2:171573442-171573729	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr2:171573270-171574024	HepG2	liver:	n/a	n/a
5	BHLHE40	chr2:171570903-171573031	HepG2	liver:	n/a	n/a
6	BHLHE40	chr2:171573466-171573774	GM12878	blood:	n/a	n/a
7	BHLHE40	chr2:171573500-171573776	A549	lung:	n/a	n/a
8	BHLHE40	chr2:171573304-171573734	HepG2	liver:	n/a	n/a
9	BRCA1	chr2:171573439-171573546	HepG2	liver:	n/a	n/a
10	CBX3	chr2:171572677-171573000	K562	blood:	n/a	n/a
11	CCNT2	chr2:171572786-171572907	K562	blood:	n/a	n/a
12	CEBPB	chr2:171573433-171573620	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr2:171573362-171573609	HepG2	liver:	n/a	n/a
14	CEBPD	chr2:171570697-171573739	HepG2	liver:	n/a	n/a
15	CHD2	chr2:171573402-171573795	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr2:171572904-171573879	HepG2	liver:	n/a	n/a
17	CREB1	chr2:171567131-171573329	HepG2	liver:	n/a	n/a
18	CREB1	chr2:171573310-171573607	A549	lung:	n/a	n/a
19	CTBP2	chr2:171573397-171574139	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr2:171573435-171573621	Lung_OC	lung:	n/a	n/a
21	CTCF	chr2:171573437-171573620	GM10266	blood:	n/a	n/a
22	CTCF	chr2:171573420-171573570	AG09319	gingival:	n/a	n/a
23	CTCF	chr2:171573440-171573590	AG04450	lung:	n/a	n/a
24	CTCF	chr2:171573360-171573510	GM12867	blood:	n/a	n/a
25	CTCF	chr2:171573386-171573687	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr2:171573383-171573635	A549	lung:	n/a	n/a
27	CTCF	chr2:171573360-171573510	HAc	cerebellar:	n/a	n/a
28	CTCF	chr2:171572700-171572850	Caco-2	colon:	n/a	n/a
29	CTCF	chr2:171573380-171573530	NHDF-neo	bronchial:	n/a	n/a
30	CTCF	chr2:171573400-171573550	Caco-2	colon:	n/a	n/a
31	CTCF	chr2:171573440-171573590	GM12867	blood:	n/a	n/a
32	CTCF	chr2:171573380-171573530	GM12864	blood:	n/a	n/a
33	CTCF	chr2:171573360-171573510	GM12873	blood:	n/a	n/a
34	CTCF	chr2:171573400-171573550	BE2_C	brain:	n/a	n/a
35	CTCF	chr2:171573398-171573584	A549	lung:	n/a	n/a
36	CTCF	chr2:171573440-171573590	HEK293	kidney:	n/a	n/a
37	CTCF	chr2:171572860-171573010	GM12869	blood:	n/a	n/a
38	CTCF	chr2:171573420-171573570	GM12875	blood:	n/a	n/a
39	CTCF	chr2:171573360-171573510	HFF-Myc	foreskin:	n/a	n/a
40	CTCF	chr2:171573460-171573610	GM12872	blood:	n/a	n/a
41	CTCF	chr2:171573440-171573590	HUVEC	blood vessel:	n/a	n/a
42	CTCF	chr2:171573380-171573530	GM12872	blood:	n/a	n/a
43	CTCF	chr2:171573460-171573610	NB4	blood:	n/a	n/a
44	CTCF	chr2:171573387-171573655	Medullo	brain:	n/a	n/a
45	CTCF	chr2:171573440-171573590	GM12874	blood:	n/a	n/a
46	CTCF	chr2:171573402-171573586	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr2:171573400-171573550	HPAF	blood vessel:	n/a	n/a
48	CTCF	chr2:171573357-171573695	IMR90	lung:	n/a	n/a
49	CTCF	chr2:171573400-171573550	HCPEpiC	choroid plexus:	n/a	n/a
50	CTCF	chr2:171573700-171573850	NHEK	skin:	n/a	n/a

(count:490 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:171573223-171573273	HEK293	kidney:	embryo
2	chr2:171572902-171572952	HCF	heart:	n/a
3	chr2:171573223-171573273	HEK293	kidney:	embryo
4	chr2:171572902-171572952	HCF	heart:	n/a
5	chr2:171572714-171572764	U87	brain:	n/a
6	chr2:171572902-171572952	U87	brain:	n/a
7	chr2:171573223-171573273	NHDF-neo	bronchial:	n/a
8	chr2:171573891-171573941	HPAEpiC	pulmonary alveolar:	n/a
9	chr2:171573891-171573941	HNPCEpiC	eye:	n/a
10	chr2:171573839-171573889	HepG2	liver:	n/a
11	chr2:171573839-171573889	GM06990	blood:	n/a
12	chr2:171573891-171573941	HMEC	breast:	n/a
13	chr2:171572900-171572950	RPTEC	kidney:	n/a
14	chr2:171573419-171573469	Hela-S3	cervix:	n/a
15	chr2:171572863-171572913	ProgFib	skin:	n/a
16	chr2:171572863-171572913	AG04449	skin:	fetal
17	chr2:171573839-171573889	HCF	heart:	n/a
18	chr2:171573839-171573889	NB4	blood:	n/a
19	chr2:171573839-171573889	Jurkat	blood:	n/a
20	chr2:171573839-171573889	ovcar-3	ovarian:	n/a
21	chr2:171573891-171573941	GM12892	blood:	n/a
22	chr2:171572714-171572764	RPTEC	kidney:	n/a
23	chr2:171573419-171573469	SK-N-MC	brain:	n/a
24	chr2:171573891-171573941	H1-hESC	embryonic stem cell:	embryo
25	chr2:171572863-171572913	PANC-1	pancreas:	n/a
26	chr2:171573891-171573941	MCF-7	breast:	n/a
27	chr2:171572902-171572952	GM19239	blood:	n/a
28	chr2:171573839-171573889	GM12892	blood:	n/a
29	chr2:171572714-171572764	SK-N-SH_RA	brain:	n/a
30	chr2:171572902-171572952	H1-hESC	embryonic stem cell:	embryo
31	chr2:171573839-171573889	PrEC	prostate:	n/a
32	chr2:171572863-171572913	GM06990	blood:	n/a
33	chr2:171572714-171572764	LNCaP	prostate:	n/a
34	chr2:171572714-171572764	HRPEpiC	eye:	n/a
35	chr2:171573891-171573941	HRCEpiC	kidney:	n/a
36	chr2:171572902-171572952	BE2_C	brain:	n/a
37	chr2:171572902-171572952	AG09319	gingival:	n/a
38	chr2:171572714-171572764	Hepatocyte	liver:	n/a
39	chr2:171572900-171572950	BJ	skin:	n/a
40	chr2:171572714-171572764	Hela-S3	cervix:	n/a
41	chr2:171573839-171573889	AoSMC	blood vessel:	n/a
42	chr2:171573419-171573469	CMK	blood:	n/a
43	chr2:171572714-171572764	HEK293	kidney:	embryo
44	chr2:171573839-171573889	MCF10A-Er-Src	breast:	n/a
45	chr2:171572900-171572950	SKMC	muscle:	n/a
46	chr2:171573891-171573941	HCT-116	colon:	n/a
47	chr2:171573839-171573889	GM12878	blood:	n/a
48	chr2:171573419-171573469	SAEC	small airway:	n/a
49	chr2:171572902-171572952	GM12892	blood:	n/a
50	chr2:171573419-171573469	NHDF-neo	bronchial:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:171571171..171574868-chr2:171624858..171628652,5	K562	blood:
2	chr2:171571182..171573160-chr2:171784797..171786624,2	K562	blood:
3	chr2:171573568..171575819-chr2:171620402..171623627,3	K562	blood:
4	chr2:171568787..171573894-chr2:171626202..171629385,10	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC007405.2.1-2	chr2:171573847-171574032	NONHSAT075413

No data

Variant related genes	Relation type
LINC01124	TF binding region
LINC01124	CpG island
ENSG00000234350	chromatin interactions
ENSG00000115806	chromatin interactions
ENSG00000239467	chromatin interactions

Extended variants
information (count: 49 )
Associated
traits (count: 44 )

Variant overlapped rSNPs/rCNVs (count:49 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs371132862	chr2:171572725-171572726	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs373186075	chr2:171572729-171572730	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs546481280	chr2:171572752-171572753	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs571538549	chr2:171572759-171572760	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs538951618	chr2:171572823-171572824	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs557377786	chr2:171572879-171572880	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs376159698	chr2:171572882-171572883	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs569319456	chr2:171572889-171572890	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs370850115	chr2:171572900-171572901	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs76206900	chr2:171572909-171572910	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs199988182	chr2:171572937-171572938	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs3749036	chr2:171572940-171572941	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs374164674	chr2:171572985-171572986	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs202245501	chr2:171573040-171573041	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs200585828	chr2:171573045-171573046	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs570319754	chr2:171573059-171573060	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs372296997	chr2:171573070-171573071	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs375931897	chr2:171573095-171573096	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs367670673	chr2:171573118-171573119	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs577104838	chr2:171573124-171573125	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs376892468	chr2:171573129-171573130	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs1134626	chr2:171573185-171573186	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs574938199	chr2:171573236-171573237	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs542270069	chr2:171573255-171573256	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs560992200	chr2:171573279-171573280	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs370150365	chr2:171573357-171573358	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs564174201	chr2:171573398-171573399	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs528196142	chr2:171573502-171573503	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs546740915	chr2:171573515-171573516	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs376566345	chr2:171573529-171573530	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs565111284	chr2:171573531-171573532	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs552837504	chr2:171573533-171573534	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs374162125	chr2:171573540-171573541	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs372466407	chr2:171573567-171573568	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs200305999	chr2:171573597-171573598	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs151104583	chr2:171573623-171573624	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs144168015	chr2:171573669-171573670	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs147780061	chr2:171573716-171573717	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs550933451	chr2:171573730-171573731	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs138180926	chr2:171573796-171573797	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs370576665	chr2:171573818-171573819	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs572881879	chr2:171573856-171573857	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
43	rs73015354	chr2:171573861-171573862	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
44	rs201188860	chr2:171573873-171573874	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
45	rs201465830	chr2:171573883-171573884	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
46	rs75866412	chr2:171573927-171573928	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
47	rs535169655	chr2:171573946-171573947	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
48	rs193297268	chr2:171573959-171573960	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
49	rs558703157	chr2:171573965-171573966	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:44)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
small cell lung cancer	20016488	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Prostate cancer	16573809	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Donnai-Barrow syndrome	21085971	CNVD
Breast cancer	21045282	CNVD
Limb abnormalities	22140379	CNVD
Sudden cardiac death	19188705	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:261 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:171569200-171573000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
2	chr2:171569400-171574400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
3	chr2:171569600-171574800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
4	chr2:171569600-171575600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
5	chr2:171570000-171573200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr2:171570000-171574000	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
7	chr2:171570000-171575600	Bivalent/Poised TSS	HepG2	liver
8	chr2:171570000-171576200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
9	chr2:171570200-171573800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
10	chr2:171570200-171574200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr2:171570200-171574400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
12	chr2:171570200-171576200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
13	chr2:171570400-171573000	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
14	chr2:171570400-171573400	Active TSS	Pancreatic Islets	Pancreatic Islet
15	chr2:171570400-171574000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
16	chr2:171570400-171574200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
17	chr2:171570400-171576200	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr2:171570600-171573000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
19	chr2:171570600-171573400	Active TSS	Aorta	Aorta
20	chr2:171570600-171574000	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
21	chr2:171570800-171574000	Bivalent/Poised TSS	HSMM	muscle
22	chr2:171571000-171572800	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
23	chr2:171571000-171572800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
24	chr2:171571000-171572800	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
25	chr2:171571200-171573000	Flanking Bivalent TSS/Enh	Primary T helper cells fromperipheralblood	blood
26	chr2:171571200-171573600	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
27	chr2:171571800-171573000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
28	chr2:171571800-171573000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr2:171571800-171573400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr2:171571800-171573600	Bivalent Enhancer	Fetal Brain Male	brain
31	chr2:171571800-171574200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
32	chr2:171571800-171574200	Bivalent Enhancer	Fetal Heart	heart
33	chr2:171571800-171575200	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr2:171571800-171577000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr2:171572000-171572800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
36	chr2:171572000-171573000	Flanking Active TSS	Ovary	ovary
37	chr2:171572200-171572800	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
38	chr2:171572200-171573200	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr2:171572200-171574400	Bivalent Enhancer	Stomach Mucosa	stomach
40	chr2:171572400-171572800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
41	chr2:171572400-171572800	Bivalent/Poised TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
42	chr2:171572400-171572800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr2:171572400-171572800	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
44	chr2:171572400-171572800	Active TSS	Lung	lung
45	chr2:171572400-171573000	Active TSS	Rectal Mucosa Donor 31	rectum
46	chr2:171572400-171573000	Bivalent Enhancer	Small Intestine	intestine
47	chr2:171572400-171573000	Bivalent/Poised TSS	Thymus	Thymus
48	chr2:171572400-171573000	Bivalent/Poised TSS	NHEK	skin
49	chr2:171572400-171573200	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
50	chr2:171572400-171573400	Bivalent/Poised TSS	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links